| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.64 | 0.8 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.47 | 0.1 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.29 | 0.3 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.28 | 0.2 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.28 | 0.3 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.27 | 0.4 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.2 | 0.4 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.2 | 0.4 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.2 | 0.5 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.2 | 0.5 |